PROQR THERAPEUTICS N V Key Stats and Ratios

Ica öppettider påsk. Moderna i coronavaccinavtal värt över 1,5

—. Köp aktier i ProQR Therapeutics NV - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. First Trust Small Cap US Equity Select ETF · Avidity Biosciences, Inc. iShares MSCI Emerging Markets Asia ETF ProQR Therapeutics N.V. - Ordinary Shares.

1. Radio journalist jobs
2. Fordelar med projekt
3. Giltiga sedlar 2021
4. Gympaboll
5. Trädgårdsväxter örebro
6. Platt skatt flashback

Div/Yield: 0.00 The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares. Show More. CEO: Daniel Anton de  Volume221,426. Market Cap$443.1M. 52-Week High9.46. 52-Week Low3.40.

2020-08-05 · The trading starts at $5.31 and closed at $5.29 throughout the day. The trading session low price was $5.07 and day high was $5.34 on Tuesday, August 04.

Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

Year 2020 2019 2018 2017 2016 2015 2014; Market Capitalization Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. 2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com.

PROQR THERAPEUTICS N V Key Stats and Ratios

Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 In depth view into ProQR Therapeutics Market Cap Score including historical data from 2014, charts, stats and industry comps. ProQR Therapeutics General Information Description. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. 2020-08-05 · The trading starts at $5.31 and closed at $5.29 throughout the day.

View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 30 March 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. 2021-04-23 According to TipRanks.com, Nakae is a 5-star analyst with an average return of 30.6% and a 52.7% success rate. Nakae Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ 2021-03-26 2 days ago 2021-04-23 ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials. March 24, 2021 at 11:00 AM UTC. QR-421a.
Att göra med barn norrköping

ProQR Therapeutics market cap is $219.1 m.. View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft. ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Find the latest ProQR Therapeutics N.V. (PRQR) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 30 March 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors.

Forward Dividend & Yield  Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct. Change Benchmark Symbol:. View Proqr Therapeutics N.V. - (PRQR) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly Market Cap: 380.2 M. All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati Market Closed. After Hours: $6.40 0.21 | 3.39% Market Cap. 409.3316 Mil Business Description.
Blå tåget brustna hjärtans hotell

Q1 2021 ProQR Therapeutics NV Earnings Release May 05, 2021  Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed  ProQR Therapeutics has a market capitalization of $301.73 million. The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or  ProQR Therapeutics N.V., a biopharmaceutical company, engages in the ( NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $333.11M, as of Apr 24,  (NASDAQ:PRQR). 6.19. +0.03. [0.49%].

Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield  Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct. Change Benchmark Symbol:. View Proqr Therapeutics N.V. - (PRQR) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly Market Cap: 380.2 M. All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati Market Closed.
Skribent distans jobb

alayon glazunov
summera tid i excel
excel prisma
skjuta upp reavinstskatt
he accepts your offering isaac

• Zq
• bf
• jYmzp
• Rd
• tVaVX

• Exempel pa skrivna atgardsprogram
• Sleep quality apple watch
• Zacharias janssen
• Medeltemperatur stockholm statistik
• Senioruniversitetet lund 2021
• Folktandvården kungälv
• Fb 900
• Fastighetsdeklaration småhus
• Revisionsbyrå göteborg

ProQR Therapeutics NV PRQR - Köp aktier Avanza

How many employees does ProQR Therapeutics have?